title: Clinicopathologic Characteristics of Gastric Cancer Patients according to the Timing of the Recurrence after Curative Surgery.
abstract: OBJECTIVE
  There are few studies that have focused on the predictors of recurrence after gastrectomy for gastric carcinoma. This study analyzed the patients who died of recurrent gastric carcinoma and we attempted to clarify the clinicopathologic factors that are associated with the timing of recurrence.
  
  
  METHODS
  From June 1992 to March 2009, 1,795 patients underwent curative gastric resection at the Department of Surgery, Hanyang University College of Medicine. Among them, 428 patients died and 311 of these patients who died of recurrent gastric carcinoma were enrolled in this study. The clinicopathologic findings were compared between the 72 patients who died within one year after curative gastrectomy (the early recurrence group) and the 92 patients who died 3 years after curative gastrectomy (the late recurrence group).
  
  
  RESULTS
  Compared with the late recurrence group, the early recurrence group showed an older age, a more advanced stage, a poorly differentiated type of cancer and a significantly higher tendency to have lymphatic invasion, vascular invasion and perineural invasion.Especially in the gastric cancer patients with a more advanced stage (stage III and IV), the early recurrence group was characterized by a significantly higher preoperative serum carcino embryonic antigen level, perineural invasion and a relatively small number of dissected lymph nodes.
  
  
  CONCLUSIONS
  The clinicopathologic characteristics of recurrent gastric cancer are significantly different according to the stage of disease, and even in the same stage. For the early detection of recurrence after curative surgery, it is important to recognize the clinicopathological factors that foretell a high risk of recurrence. It is mandatory to make an individualized surveillance schedule according to the clinicopathologic factors.
authors.affiliation: Department of Surgery, Hanyang University College of Medicine, Seoul, Korea.
authors.forename: Ji Yoon
authors.initials: JY
authors.lastname: Choi
authors.forename: Tae Kyung
authors.initials: TK
authors.lastname: Ha
authors.forename: Sung Joon
authors.initials: SJ
authors.lastname: Kwon
references.citation: Int Surg. 2009 Apr-Jun;94(2):144-8
references.pmid: 20108618
references.citation: Ann Surg Oncol. 2009 Jul;16(7):1896-902
references.pmid: 19434457
references.citation: Eur J Surg Oncol. 2003 Aug;29(6):506-10
references.pmid: 12875856
references.citation: Am J Clin Oncol. 2004 Apr;27(2):205-9
references.pmid: 15057162
references.citation: Gan To Kagaku Ryoho. 2009 Sep;36(9):1402-7
references.pmid: 19755807
references.citation: Hepatogastroenterology. 2009 Nov-Dec;56(96):1760-4
references.pmid: 20214233
references.citation: Surg Oncol. 2010 Mar;19(1):4-10
references.pmid: 19042124
references.citation: Ann Surg Oncol. 2010 Aug;17(8):2037-44
references.pmid: 20333555
references.citation: Ann Surg Oncol. 2009 Nov;16(11):3028-37
references.pmid: 19626373
references.citation: J Clin Oncol. 2010 May 10;28(14):2430-6
references.pmid: 20368551
references.citation: Jpn J Clin Oncol. 2003 May;33(5):209-14
references.pmid: 12865463
references.citation: Ups J Med Sci. 2002;107(1):17-22
references.pmid: 12296449
references.citation: Med Oncol. 2011 Dec;28(4):973-80
references.pmid: 20517658
references.citation: Br J Surg. 2006 Feb;93(2):205-9
references.pmid: 16363019
references.citation: Cancer. 1994 Feb 1;73(3):550-5
references.pmid: 8299076
references.citation: Cancer. 2000 Jul 15;89(2):255-61
references.pmid: 10918153
references.citation: J Korean Med Sci. 2009 Dec;24(6):1158-64
references.pmid: 19949675